Clinical outcomes, molecular epidemiology and resistance mechanisms of multidrug-resistant Pseudomonas aeruginosa isolated from bloodstream infections from Qatar-Reference-Cited by-同舟云学术

Clinical outcomes, molecular epidemiology and resistance mechanisms of multidrug-resistant Pseudomonas aeruginosa isolated from bloodstream infections from Qatar

Published:2021-01-01 Issue:1 Volume:53 Page:2345-2353
ISSN:0785-3890
Container-title:Annals of Medicine
language:en
Short-container-title:Annals of Medicine

Author:

Sid Ahmed Mazen A.¹²^ORCID,Hamid Jemal M.¹,Husain Ahmed A.³⁴,Hadi Hamad Abdel³⁴,Skariah Sini⁵,Sultan Ali A.⁵,Ibrahim Emad Bashir¹⁶,Al Khal Abdul Latif³⁴,Soderquist Bo⁷,Jass Jana²,Omrani Ali S.³⁴

Affiliation:

1. Department of Pathology and Laboratory Medicine, Division of Microbiology, Hamad Medical Corporation, Doha, Qatar

2. The Life Science Centre, School of Science and Technology, Örebro University, Örebro, Sweden

3. Department of Medicine, Division of Infectious Diseases, Hamad Medical Corporation, Doha, Qatar

4. Communicable Diseases Center, Hamad Medical Corporation, Doha, Qatar

5. Department of Microbiology and Immunology, Weill Cornell Medicine-Qatar, Doha, Qatar

6. Biomedical Research Centre, Qatar University, Doha, Qatar

7. School of Medical Sciences, Faculty of Medicine and Health, Orebro University, Orebro, Sweden

Funder

Hamad Medical Corporation, Doha, Qatar

National Priorities Research Program

Swedish Research Council

Hamad Medical Corporation

Qatar National Research Fund

Publisher

Informa UK Limited

Subject

General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/07853890.2021.2012588

Reference34 articles.

1. Epidemiology and Treatment of Multidrug-Resistant and Extensively Drug-Resistant Pseudomonas aeruginosa Infections

2. Multidrug-resistant Pseudomonas aeruginosa bloodstream infections: risk factors and mortality

3. Clinical and economic consequences of hospital-acquired resistant and multidrug-resistant Pseudomonas aeruginosa infections: a systematic review and meta-analysis

4. Predictors of 30-Day Mortality among Patients with Pseudomonas aeruginosa Bloodstream Infections: Impact of Delayed Appropriate Antibiotic Selection

5. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Incidence, antimicrobial resistance and mortality of Pseudomonas aeruginosa bloodstream infections among hospitalized patients in China: a retrospective observational multicenter cohort study from 2017 to 2021;Frontiers in Public Health;2024-01-05

2. Antimicrobial Treatment of Pseudomonas aeruginosa Severe Sepsis;Antibiotics;2022-10-18